相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Carvedilol attenuates paraquat-induced lung injury by inhibition of proinflammatory cytokines, chemokine MCP-1, NF-κB activation and oxidative stress mediators
Keyvan Amirshahrokhi et al.
CYTOKINE (2016)
Doxycycline and Benznidazole Reduce the Profile of Th1, Th2, and Th17 Chemokines and Chemokine Receptors in Cardiac Tissue from Chronic Trypanosoma cruzi-Infected Dogs
Guilherme de Paula Costa et al.
MEDIATORS OF INFLAMMATION (2016)
Inflammation Enhances the Risks of Stroke and Death in Chronic Chagas Disease Patients
Paulo Marcos Matta Guedes et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Enalapril in Combination with Benznidazole Reduces Cardiac Inflammation and Creatine Kinases in Mice Chronically Infected with Trypanosoma cruzi
Arlete Rita Penitente et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)
Vasoactive intestinal peptide reduces the inflammatory profile in mice infected with Trypanosoma cruzi
Pulcheria Maria Silva Higyno et al.
EXPERIMENTAL PARASITOLOGY (2015)
Old and new challenges in Chagas disease
Jose A. Perez-Molina et al.
LANCET INFECTIOUS DISEASES (2015)
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy
C. A. Morillo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Interleukin-10 and tumour necrosis factor-alpha serum levels in chronic Chagas disease patients
R. H. T. Vasconcelos et al.
PARASITE IMMUNOLOGY (2015)
Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway
Qian Ding et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Differential Activation of Human Monocytes and Lymphocytes by Distinct Strains of Trypanosoma cruzi
Luisa M. D. Magalhaes et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Developments in the management of Chagas cardiomyopathy
Herbert B. Tanowitz et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2015)
Biomarkers and Mortality in Severe Chagas Cardiomyopathy
Jacqueline E. Sherbuk et al.
GLOBAL HEART (2015)
Immunopharmacological Approach of Carvedilol in Chronic Chagas Heart Disease
Carla Paixao Miranda et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2014)
Carvedilol Enhances the Antioxidant Effect of Vitamins E and C in Chronic Chagas Heart Disease
Patricia Budni et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2013)
Carvedilol Decrease IL-1β and TNF-α, Inhibits MMP-2, MMP-9, COX-2, and RANKL Expression, and Up-Regulates OPG in a Rat Model of Periodontitis
Raimundo Fernandes de Araujo Junior et al.
PLOS ONE (2013)
Myocardial scars correlate with eletrocardiographic changes in chronic Trypanosoma cruzi infection for dogs treated with Benznidazole
Ivo Santana Caldas et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2013)
Carvedilol Attenuates Oxidative Stress in Chronic Chagasic Cardiomyopathy
Patricia Budni et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2012)
Cardiomyopathy prognosis after benznidazole treatment in chronic canine Chagas' disease
Fabiane M. Santos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease
Rafael Rodrigues Silva et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2012)
Use of carvedilol in hypertension: an update
Gastone Leonetti et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2012)
Drug Therapy of Heart Failure: An Immunologic View
Ehab S. El Desoky
AMERICAN JOURNAL OF THERAPEUTICS (2011)
Low Doses of Simvastatin Therapy Ameliorate Cardiac Inflammatory Remodeling in Trypanosoma cruzi-Infected Dogs
Lilian Melo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Identification of genes encoding hypothetical proteins in open-reading frame expressed sequence tags from mammalian stages of Trypanosoma cruzi
C. Martins et al.
GENETICS AND MOLECULAR RESEARCH (2011)
The inhibition in tumor necrosis factor-alpha-induced attenuation in endothelial thrombomodulin expression by carvedilol is mediated by nuclear factor-kappa B and reactive oxygen species
Pen-Yuan Lin et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2010)
Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease
Margoth Moreno et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2010)
Role of CCL3/MIP-1α and CCL5/RANTES during acute Trypanosoma cruzi infection in rats
Ester Roffe et al.
MICROBES AND INFECTION (2010)
The Effect of Beta-Blockers on the Adaptive Immune System in Chronic Heart Failure
Steven M. Shaw et al.
CARDIOVASCULAR THERAPEUTICS (2009)
CCL2/MCP-1 controls parasite burden, cell infiltration, and mononuclear activation during acute Trypanosoma cruzi infection
Claudia N. Paiva et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions
Ivo Santana Caldas et al.
PARASITOLOGY RESEARCH (2008)
A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy
Fernando A. Botoni et al.
AMERICAN HEART JOURNAL (2007)
Differential transcription profiles in Trypanosoma cruzi associated with clinical forms of Chagas disease:: Maxicircle NADH dehydrogenase subunit 7 gene truncation in asymptomatic patient isolates
Cassio S. Baptista et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2006)
Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction
Bin Li et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human Chagas disease
Rajendranath Ramasawmy et al.
CLINICAL INFECTIOUS DISEASES (2006)
Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis -: Association with reduced myocardial interleukin-1β and MMP-8 expression and a modulated immune response
M Pauschinger et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Elevated concentrations of CCL2 and tumor necrosis factor-α in chagasic cardiomyopathy
A Talvani et al.
CLINICAL INFECTIOUS DISEASES (2004)
Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a thl-specific immune response
JAS Gomes et al.
INFECTION AND IMMUNITY (2003)
Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine
MC Gerson et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2002)
Chemokines, inflammation and Trypanosoma cruzi infection
MM Teixeira et al.
TRENDS IN PARASITOLOGY (2002)
Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy
T Ohtsuka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
β-adrenergic blockade in developing heart failure -: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling
SD Prabhu et al.
CIRCULATION (2000)
分享论文
